论文部分内容阅读
山东信得科技股份有限公司现拥有北京信得威特科技有限公司、四川华西动物药业有限公司、青岛信得药业有限公司三家全资和控股子公司。在今年的中国畜牧业暨饲料工业展览会上,信得科技禽药制剂、畜药制剂、饲料添加剂、疫苗(北京信得)、代理疫苗(罗曼等)、原料药六大业务集体亮相,而更加引起参会者关注的,是会上高调推出的三个生化产品:脾转移因子产品——信必妥、鸭肝抗体及小鹅瘟抗体。信得科技在今年的展会上展出了一系列新产品:其中自产苗业务(北京信得威特)一下子推出了二十九个疫苗产品;兽药制剂展示了纳米乳和
Shandong letter Technology Co., Ltd. now has a letter from Beijing Witt Technology Co., Ltd., Sichuan Huaxi Animal Pharmaceutical Co., Ltd., Qingdao letter Pharmaceutical Co., Ltd. three wholly-owned and holding subsidiaries. At this year’s China Animal Husbandry and Feed Industry Exhibition, the six businesses of Xinde Technology Poultry Preparations, Animal Medicine Preparations, Feed Additives, Vaccines (Beijing Xinde), Agent Vaccine (Luoman etc.) and APIs collectively appeared More aroused the attendees’ attention, the three biochemical products launched by the conference with high profile: the spleen transfer factor product, namely seretide, duck liver antibody and gosling plague antibody. In this year’s show, ShinTech exhibited a series of new products: among them, the self-made seedling business (Beijing XinWeitite) launched 29 vaccine products at one go; the veterinary drug product showed nanometer milk and